Larry Lyons - Concepedia

Author

Larry Lyons

Also Known As

L. Lyons, L.F. Lyons, Larry Lyons, Larry Lyons*

Publications

338

Citations

H-Index

Concepts

All Affiliations

Larry Lyons is an author at Froedtert Hospital specializing in medicine, pharmacology, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	85
2	Pharmacology	2	2	85
3	Health Sciences	1	1	29
4	Immunology	1	1	29
5	Cancer Cell Biology	1	1	29

Larry Lyons

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Open-label, Phase I Study of Nivolumab Combined with <i>nab</i> -Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer Zev A. Wainberg, Howard S. Höchster, Edward Kim, Clinical Cancer Research	2020	146
BLT-D (Clarithromycin [Biaxin], Low-Dose Thalidomide, and Dexamethasone) for the Treatment of Myeloma and Waldenström's Macroglobulinemia Morton Coleman, John P. Leonard, Larry Lyons, Leukemia & lymphoma/Leukemia and lymphoma	2002	79
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone Morton Coleman, John P. Leonard, Larry Lyons, Seminars in Oncology Translational MedicineMedicineHematologyPharmacologyLow-dose Thalidomide	2003	56
Phase I study of nivolumab (Nivo) + <i>nab</i>-paclitaxel (<i>nab</i>-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC). Zev A. Wainberg, Howard S. Höchster, Edward Kim, Journal of Clinical Oncology ImmunologyImmunotherapeuticsImmunotherapyPancreatic CancerGastrointestinal Oncology	2019	29
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Jonathan W. Goldman, David Waterhouse, Ben George, Frontiers in Oncology	2019	12

Page 1